Webinar
The concept of borderline personality disorder (BPD) was defined nearly 100 years ago, and its diagnosis has been part of clinical practice for almost 50 years. What have we learnt about treating BPD? Initially, portrayed as one of the most difficult psychiatric disorders to treat, the past 30 years of innovations have led to substantial amelioration in psychotherapeutic interventions, yielding clear benefits in the lives of people with the diagnosis of BPD. Intense affect, accompanied by powerful fear of abandonment, self-harming behaviors, interpersonal turmoil and identity disturbances have been conceptualized by different and sometimes opposed psychotherapeutic approaches, yet many empirically-tested treatments seem to yield significant therapeutic change. What are the mechanisms employed by clinicians to tackle the clinical features of BPD? The keynote speakers and panelists of this webinar will address these questions, with respect to both adults and youths suffering from BPD, and shed light on some of the current clinical challenges and possible avenues of future development in psychotherapy for BPD.
Our May keynote lecture is shared by two prominent experts in the field of borderline personality disorder, Professor Svenja Taubner and Dr. Shelley McMain, Ph.D., C.Psych., who will focus on two different aspects of the disorder.
The presentation will be followed by a panel discussion.
Keynote Lecture #1
Far from Causality - Understanding Mechanisms of Change in the Treatment of BPD in Young People
Speaker: Professor Svenja Taubner
Until recently, no common or specific change factors in psychotherapy have been empirically validated. The proposed change mechanisms within the evidence-based psychotherapies in the treatment of BPD vary considerably from changes in emotion regulation in the Dialectic Behavior Therapy (DBT), changes in mentalizing and epistemic trust in the Mentalization-Based Treatment (MBT) or changes in identity in the Transference-Focused Psychotherapy (TFP). However, change mechanisms seem to be all related to changes in personality functioning. In this talk, Professor Taubner will take a critical stance towards the empirical evidence of the proposed change mechanisms. She will draw recommendations for the future of research on change mechanism from a recent systematic review on change mechanisms in the psychotherapeutic treatment of adolescents.
Keynote Speaker
Svenja Taubner, Prof. Dr. phil., Dipl.-Psych. – is a psychologist, psychotherapist, and a certified psychoanalyst (German Society for Psychoanalysis, DPG), trainer and supervisor for Mentalization-Based-Treatment and Psychodynamic Psychotherapy. She specializes in the development and evaluation of intervention and prevention programs for families, individuals and mental health professionals. Currently, Professor Taubner is the Director of the Institute for Psychosocial Prevention at the University Hospital Heidelberg (since 2016). She is also a Co-Speaker of a DFG-Graduate School Application on enmity studies. Previously, she held the position of a Full Professor for Clinical Psychology & Psychotherapy at Klagenfurt University, Austria (2012-2015), and Jun. Prof. for Developmental Psychopathology at the International Psychoanalytic University Berlin (2010-2012). Her main research interests include mentalization, psychotherapy, personality disorders, aggression, and competences of mental health professionals.
Keynote Lecture #2
Advances in Psychotherapy for Borderline Personality Disorder
Speaker: Dr. Shelley McMain, Ph.D., C.Psych.
Borderline personality disorder is a severe mental health disorder associated with high rates of morbidity and mortality. Psychotherapy is recognized as a first-line treatment for BPD. The past few decades has witnessed promising advancements in the development of psychotherapy for BPD. This presentation summarizes some recent developments in the field of psychotherapy for BPD, highlights some of the current challenges, and points to directions for future treatment and psychotherapy research.
Keynote Speaker
Dr. Shelley McMain, Ph.D., C.Psych. – is the Head of the Borderline Personality Disorder Clinic and a Clinician Scientist at the Centre for Addiction and Mental Health in Toronto, Canada. She is the Director of the Psychotherapy, Humanities, and Psychosocial Interventions Division and an Associate Professor in the Department of Psychiatry at the University of Toronto, Canada. She has received several awards for her psychotherapy research, including the recent Award for Achievement in the Field of Severe Personality Disorders from the Personality Disorders Institute at the University Hospital of Columbia and Cornell in New York (2020). She is the President of the Society for Psychotherapy Research. Her major areas of research interest include therapy of borderline personality disorder (BPD) such as Dialectical Behaviour Therapy and the mechanisms and mediators of psychotherapy outcomes. Dr. McMain is the acting President of the newly established World DBT Association.
Panel Discussion
Borderline Personality Disorder: Different treatments, same mechanisms of change?
Panelists will include Dr. Gitta Jacob, Professor Martin Debbané, and our Keynote Speakers: Professor Svenja Taubner and Dr. Shelley McMain
Panel Host: Professor Martin Debbané
Panel Host
Martin Debbané – is Associate Professor at the Faculty of Psychology and Educational Sciences, University of Geneva (Switzerland), and Professor of Psychopathology at the Research Department of Clinical, Educational, and Health Psychology, University College London (UK). His research focuses on the development of psychopathology in youths and young adults, integrating clinical, experimental and developmental psychology methods together with neuroscientific research. He is trainer, supervisor and practitioner of mentalization-based therapy, with a specialization in early psychosis, personality disorders and ADHD.
Panelists
Dr. Gitta Jacob, – studied psychology in Würzburg and Freiburg, obtained her Ph.D. from the university of Freiburg in 2001, was licensed as a CBT therapist in 2003, and worked as a post-doc at the University Medical Center Freiburg and the University of Freiburg from 2002-2013. Her main field of interest at the university was Borderline Personality Disorder, with a therapeutic focus on Schema Therapy and emotion-focussed techniques in general. In 2013 she joined GAIA in Hamburg, the globally leading company in the field of digital therapeutics. At GAIA she is responsible for the development of new therapeutic software applications and their integration in patient care. Besides developing software applications for BPD, she is also involved in a broad range of other indications such as pain, diabetes or psychooncology. She authored and co-authored more than 100 scientific papers, book chapters and books. Her books have been translated into 15 languages.
If you are interested in clinical psychology and therapy, please review the information on the upcoming EACLIPT 2022 Conference »